Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome

NCT00406926 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00406926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00406926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1999
Completion date
August 31, 2003
Enrollment
100
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

turner syndrome